scispace - formally typeset
D

David S. Bredt

Researcher at Johnson & Johnson

Publications -  224
Citations -  63974

David S. Bredt is an academic researcher from Johnson & Johnson. The author has contributed to research in topics: Nitric oxide synthase & Nitric oxide. The author has an hindex of 107, co-authored 223 publications receiving 62332 citations. Previous affiliations of David S. Bredt include Johns Hopkins University & Georgetown University Medical Center.

Papers
More filters
Journal ArticleDOI

Actinin-associated LIM protein-deficient mice maintain normal development and structure of skeletal muscle.

TL;DR: In this paper, the authors describe the generation and analysis of mice lacking the actinin-associated LIM protein (ALP) gene and show that the absence of a dystrophic phenotype in these mice suggests that down-regulation of ALP does not participate in facioscapulohumeral muscular dystrophy.
Journal ArticleDOI

Distribution of postsynaptic density proteins in rat kidney: relationship to neuronal nitric oxide synthase.

TL;DR: PSD-93 is the predominant PSD expressed in the rat kidney and is located primarily in the basolateral membranes of distal nephron and colocalizes with a pool of nNOS in cytoplasmic vesicles and basol lateral membranes of macula densa cells.
Journal ArticleDOI

Early events in glutamate receptor trafficking

TL;DR: This work shows that receptor exit from the endoplasmic reticulum represents a critical regulatory step in glutamate receptor trafficking to the neuronal cell surface.
Journal ArticleDOI

Identification of a monogenic locus (jams1) causing juvenile audiogenic seizures in mice.

TL;DR: It is reported that Black Swiss mice have a heretofore unrecognized specific susceptibility to audiogenic seizures, which may provide important insight into the fundamental mechanisms for developmentally regulated human epilepsy syndromes.
Journal ArticleDOI

Polyamine regulation of ion channel assembly and implications for nicotinic acetylcholine receptor pharmacology.

TL;DR: It is revealed that cellular polyamines control nicotinic acetylcholine receptor (nAChR) biogenesis, and either catabolic degradation or inhibition of polyamine production augments nACh R assembly.